Isk Biosciences India Profile
Key Indicators
- Authorised Capital ₹ 17.50 Cr
- Paid Up Capital ₹ 17.50 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 31.64%
- Profit Growth 966.04%
- Ebitda 205.58%
- Net Worth 10.02%
- Total Assets 111.13%
About Isk Biosciences India
Isk Biosciences India Private Limited (IBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 April 2015 (Nine years and nine months 27 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 17.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Isk Biosciences India Private Limited India is Sweety as COMPANY SECRETARY. Umesh Khaitan, Mikiya Horie, Kiyomitsu Yoshida, and Three other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100DL2015PTC278699
- Company No.
278699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2015
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Isk Biosciences India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Premnath  | Managing Director | 17-Feb-2023 | Current |
| Sweety | Company Secretary | 14-Nov-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Khaitan | Director | 06-Apr-2015 | Current |
Mikiya Horie  | Director | 08-Aug-2016 | Current |
| Kiyomitsu Yoshida | Director | 05-Oct-2018 | Current |
| Shimpei Nemoto | Director | 27-May-2024 | Current |
| Masateru Oguri | Director | 25-Sep-2024 | Current |
Financial Performance of Isk Biosciences India.
Isk Biosciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.64% increase. The company also saw a substantial improvement in profitability, with a 966.04% increase in profit. The company's net worth Soared by an impressive increase of 10.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Isk Biosciences India?
In 2023, Isk Biosciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Modi Rubber LimitedUmesh Khaitan is a mutual person
Cremica Food Industries LimitedUmesh Khaitan is a mutual person
Metro Tyres LimitedUmesh Khaitan is a mutual person
Sutlej Textiles And Industries LimitedUmesh Khaitan is a mutual person
Combine Agritech LlpUmesh Khaitan is a mutual person
- Ghaziabad Investmentlimited
Umesh Khaitan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Isk Biosciences India?
Isk Biosciences India has a workforce of 2 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Isk Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isk Biosciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
